On March 1, 2024 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, reported that senior leadership plans to present at the following conferences (Press release, Iovance Biotherapeutics, MAR 1, 2024, View Source [SID1234640699]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen’s 44th Annual Health Care Conference
Fireside Chat: March 4, 2024 at 11:10 a.m. ET
Boston, MA
Barclays 26th Annual Global Healthcare Conference
Fireside Chat: March 12, 2024 at 10:45 a.m. ET
Miami, FL
H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Fireside Chat: March 26, 2024 at 1:30 p.m. ET
Virtual
The live and archived webcasts will be available at View Source